Clinical Trials in Tashkent, Uzbekistan
2 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 1
Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.
Type 2 Diabetes
Eilean Therapeutics60 enrolled5 locationsNCT07234864
Recruiting
Not Applicable
ColoSeal™ ICD System Safety and Feasibility Study
Colorectal, Cancer
Averto Medical, Inc.15 enrolled3 locationsNCT06402188
Recruiting
Not Applicable
Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device
Atrial Fibrillation
Endomatic Ltd.15 enrolled5 locationsNCT06099106